AbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition
Shares of AbbVie (NYSE:ABBV) sank on Friday after the pharmaceutical company reported first-quarter results. Despite beating earnings estimates ($2...#abbvie (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
By almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant delivered first-quarter sales and earnings results that topped estimates. The decline in sales of multi-indication immunosuppressive drug Humira -- a natural result of its loss of patent…#humira #abbvie #rinvoq #imbruvica #jamesbrumley #earningsbeat (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
AbbVie looks to Skyrizi, other drugs to replace blockbuster Humira sales
Sales of Skyrizi and Rinvoq jumped in the first quarter for AbbVie, while Humira sales slid. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Ben Miller Source Type: news
AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title
AbbVie stock was muted Friday after beating first-quarter expectations as Humira sales continue falling. Skyrizi is catching up, though. The post AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title appeared first on Investor's Business Daily.#abbvie #humira #skyrizilooks #title (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
If you're building a stream of dividend income to fuel your retirement dreams, it helps to fill your portfolio with businesses that can keep growing through a wide range of economic conditions. Healthcare expenses are generally unavoidable, which makes it a great sector to look for stocks with…#healthcare #abbvie #bristolmyerssquibb #bmy #johnsonjohnson #jnj #abbottlaboratories #humira #rinvoq #fda (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news
3 No-Brainer Dividend Stocks to Buy in April
Three Motley Fool contributors have dividends on their minds as the second quarter of 2024 begins. And they think they've found some no-brainer dividend stocks to buy in April. Here's why they like AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE). One of the most…#abbvie #gileadsciences #gild #pfe #keithspeights #abbottlabs #dividendking #abbott #humira #rinvoq (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
The'Extremely Positive' Results That Helped Roivant Leapfrog Its 50-Day Line, Nearing A Breakout
Roivant stock is nearing a breakout Tuesday after the biotech company announced positive results in an eye-disease study and a $1.5 billion share repurchase. The company enrolled 26 patients with noninfectious uveitis, a condition that causes inflammation in one or both eyes. Roivant Sciences…#roivantsciences #leerinkpartners #davidrisinger #humira #abbvie #mattgline #allisongatlin #ibdagatlin (Source: Reuters: Health)
Source: Reuters: Health - April 3, 2024 Category: Consumer Health News Source Type: news
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
There are many ways the stock market can help you get rich, but not every method is right for you. If you're someone who enjoys keeping tabs on fast-moving industries, chasing popular growth stocks makes sense. For those of us who are more concerned with retiring comfortably, finding stocks we can…#medicare #johnsonjohnson #jnj #abiomed #shockwavemedical #medtronic #abbvie #abbottlaboratories #humira #skyrizi (Source: Reuters: Health)
Source: Reuters: Health - March 30, 2024 Category: Consumer Health News Source Type: news
Industry payments to radiologists total out at $392M
Out of 39 specialties, radiology was in the top third when ranked by industry payments to doctors over a nine-year period, according to an article published March 28 in JAMA.Between August 2013 and December 2022, 50% of 68,718 radiologists received industry payments totaling $392 million, lead author Ahmed Sayed, of Ain Shams University in Cairo, Egypt, and U.S. colleagues reported. The total for all U.S. physicians over the period was $12.1 billion.“Despite evidence that financial conflicts of interest may influence physician prescribing and may damage patients’ trust in medical professionals, such relationships remai...
Source: AuntMinnie.com Headlines - March 28, 2024 Category: Radiology Authors: Will Morton Tags: Practice Management Source Type: news
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Pharmaceutical companies play a tremendous role in modern healthcare. While sometimes controversial, drugmakers design medicine to treat some of the worst ailments plaguing society and constantly innovate to improve human life. Their long-term relevance in healthcare makes the pharmaceutical…#healthcare #pfe #pfizer #seagen #abbvie #abbottlaboratories #humira #botox #allergan #rinvoq (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
These 6 Dividend Kings Could Be The Best Stocks The Rest Of 2024
Over the last two years, interest rates have jumped from historical lows of literally 0% to the highest level since 2007 at 5.5%. 30 FHA Mortgages have jumped from 2.65% in January of 2021 to the current 7.24% rate. During that period, any stock that was the least sensitive to interest rates got…#fhamortgages #federalreserve #dividendking #abbvie #abbvieinc #abbottlaboratories #dyslipidemia #humira #allerganplc #allergan (Source: Reuters: Health)
Source: Reuters: Health - March 7, 2024 Category: Consumer Health News Source Type: news
5 Dividend Aristocrat Stocks Quietly Offering Huge Total Return Potential
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In other words, the total return on an investment or a portfolio…#dividend #abbvie #abbvieinc #abbottlaboratories #dyslipidemia #humira #allerganplc #allergan #botox #exxonmobil (Source: Reuters: Health)
Source: Reuters: Health - February 27, 2024 Category: Consumer Health News Source Type: news
FDA OKs 10th Humira Biosimilar, Interchangeability Included FDA OKs 10th Humira Biosimilar, Interchangeability Included
It is the tenth adalimumab biosimilar approved by the regulatory agency.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 26, 2024 Category: Internal Medicine Tags: Rheumatology Source Type: news
FDA OKs First Interchangeable Humira Biosimilar FDA OKs First Interchangeable Humira Biosimilar
It is the tenth adalimumab biosimilar approved by the regulatory agency.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - February 26, 2024 Category: Pediatrics Tags: Rheumatology Source Type: news
Why Is Teva Pharma Stock Trading Higher Today?
Friday, Alvotech ALVO and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd TEVA, announced the FDA approved Simlandi (adalimumab-ryvk) injection, as an interchangeable biosimilar to AbbVie Inc’s ABBV Humira. The biosimilar is indicated for adult rheumatoid arthritis,…#alvotech #tevapharmaceuticals #fda #abbvieincs #abbvhumira #crohn #humira #teva #tevapharma #splitspeculations (Source: Reuters: Health)
Source: Reuters: Health - February 26, 2024 Category: Consumer Health News Source Type: news
